Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Santus

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Pulmonary Pharmacology & Therapeutics|November 4, 2000
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonistM Cazzola, B Boveri, P Carlucci, et al.
Respiratory Medicine|December 13, 2005
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflationP Santus, S Centanni, M Verga, et al.
Minerva Medica|July 19, 2016
Choose the best route: ultrasound-guided transbronchial and transesophageal needle aspiration with echobronchoscope in the diagnosis of mediastinal and pulmonary lesionsM Mondoni, A D'Adda, S Terraneo, et al.
The European Respiratory Journal|February 7, 2003
Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expirationP Santus, M Pecchiari, P Carlucci, et al.
Minerva Medica|November 20, 2015
Choose the best route: ultrasound-guided transbronchial and transesophageal needle aspiration with echobronchoscope in the diagnosis of mediastinal and pulmonary lesionsM Mondoni, A D'adda, S Terraneo, et al.
Respiration; International Review of Thoracic Diseases|March 8, 2000
Non-pulmonary effects induced by the addition of formoterol to budesonide therapy in patients with mild or moderate persistent asthmaS Centanni, P Carlucci, P Santus, et al.
Pulmonary Pharmacology & Therapeutics|May 5, 2004
Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPDM Cazzola, P Santus, F Di Marco, et al.
Respiratory Medicine|May 9, 2003
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPDM Cazzola, P Santus, M G Matera, et al.
Respiratory Medicine|December 14, 2004
The functional impact of adding salmeterol and tiotropium in patients with stable COPDM Cazzola, S Centanni, P Santus, et al.
Respiration; International Review of Thoracic Diseases|November 6, 2001
Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary diseaseM Cazzola, S Centanni, B Boveri, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Pulmonary Pharmacology & Therapeutics|November 4, 2000
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonistM Cazzola, B Boveri, P Carlucci, et al.
Respiratory Medicine|December 13, 2005
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflationP Santus, S Centanni, M Verga, et al.
Minerva Medica|July 19, 2016
Choose the best route: ultrasound-guided transbronchial and transesophageal needle aspiration with echobronchoscope in the diagnosis of mediastinal and pulmonary lesionsM Mondoni, A D'Adda, S Terraneo, et al.
The European Respiratory Journal|February 7, 2003
Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expirationP Santus, M Pecchiari, P Carlucci, et al.
Minerva Medica|November 20, 2015
Choose the best route: ultrasound-guided transbronchial and transesophageal needle aspiration with echobronchoscope in the diagnosis of mediastinal and pulmonary lesionsM Mondoni, A D'adda, S Terraneo, et al.
Respiration; International Review of Thoracic Diseases|March 8, 2000
Non-pulmonary effects induced by the addition of formoterol to budesonide therapy in patients with mild or moderate persistent asthmaS Centanni, P Carlucci, P Santus, et al.
Pulmonary Pharmacology & Therapeutics|May 5, 2004
Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPDM Cazzola, P Santus, F Di Marco, et al.
Respiratory Medicine|May 9, 2003
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPDM Cazzola, P Santus, M G Matera, et al.
Respiratory Medicine|December 14, 2004
The functional impact of adding salmeterol and tiotropium in patients with stable COPDM Cazzola, S Centanni, P Santus, et al.
Respiration; International Review of Thoracic Diseases|November 6, 2001
Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary diseaseM Cazzola, S Centanni, B Boveri, et al.
Pageof 6